CD8 T Cells Target Antigen Cross-Presented by Bone Marrow Derived Cells to Induce Bystander Rejection of Grafts Lacking the Cognate Peptide-MHC

CD8 T cells play a key role in cancer immunotherapy and allograft rejection. However, it is not clear how they kill cells and tissues that do not have the agonist peptide-major histocompatibility complex (MHC) on their surface, as in the settings of MHC class I deficient tumors and indirect rejectio...

全面介紹

書目詳細資料

發表在:	Cell Transplantation
Main Authors:	David P. Al-Adra, Govindarajan Thangavelu, Jiaxin Lin, William F.N. Chan, Kristofor K. Ellestad, Louis Boon, Colin C. Anderson
格式:	Article
語言:	英语
出版:	SAGE Publishing 2022-11-01
在線閱讀:	https://doi.org/10.1177/09636897221136149